SCM
BMY icon

Stellar Capital Management’s Bristol-Myers Squibb BMY Stock Holding History

Stellar Capital Management’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		$2.89M Buy
49,181
+17,307
+54% +$1.04M 1.97% 21
2020
Q1 		$1.78M Buy
31,874
+1,831
+6% +$112K 1.46% 27
2019
Q4 		$1.93M Buy
30,043
+7,336
+32% +$420K 1.13% 37
2019
Q3 		$1.15M Buy
+22,707
New +$1.07M 0.74% 41

Other funds holding BMY

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Stellar Capital Management's BMY Position: Q2 2020 in Review

Stellar Capital Management increased its Bristol-Myers Squibb (BMY) stake by 54% in Q2 2020, buying an estimated $1.04M and bringing the position to 49,181 shares worth $2.89M. The position accounts for 1.97% of the portfolio, ranked #21.

Stellar Capital Management first reported a position in BMY in Q3 2019 and has held it in 4 quarters since. 2,189 funds tracked by Wall St. Rank hold BMY as of Q2 2020.

  • Stellar Capital Management held 49,181 shares of Bristol-Myers Squibb worth $2.89M as of Q2 2020.
  • Stellar Capital Management bought 17,307 Bristol-Myers Squibb shares in Q2 2020, an estimated $1.04M.
  • Bristol-Myers Squibb made up 1.97% of Stellar Capital Management's portfolio in Q2 2020, its #21 holding.
  • Stellar Capital Management first reported a position in Bristol-Myers Squibb in Q3 2019 and has held it in 4 quarters since.
  • 2,189 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2020.

Based on Stellar Capital Management's 13F filing for Q2 2020, filed 17 Aug 2020.